centro médico de San José s http://www.totmataro.cat/comprar-kamagra.html Cuál es el mejor seguro de salud http://www.totmataro.cat/cialis-20mg-precio.html píldoras de la dieta libre de cafeína

Presentaciones

| 21 noviembre, 2017

Tuesday, November 14th 2017

09:05 – 10:00 h 1st SESSION: EPIGENOMIC AND CANCER

09:05 – 09:20 h Small molecules targeting epigenetic modulators for cancer treatment

Dr. Xabier Aguirre, Centro de Investigación Médica Aplicada-CIMA, Universidad de Navarra, Pamplona

Presentación  


09:20 – 09:35 h Transfer RNA methylation in cancer

Dra. Sandra Blanco, CIC bioGUNE, Derio

Presentación  


09:35 – 09:40 h Oral communication Inhibition of a G9A-EZH2 network triggers an immune-mediated bladder cancer regression

Dra. Cristina Segovia, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas-CIEMAT, Madrid

Presentación  


09:40 – 09:45 h Oral communication Correlation between tumor history and microenvironment using multiregion single-molecule epigenomic data from colorectal cancer patients

Dr. José Luis Soto, Universidad de Vigo

Presentación  


10:00 – 10:35 h EMERGING TOPICS IN CANCER: TUMOR EVOLUTION

10:05 – 10:30 h Speaker:

Dr. David Posada, Universidad de Vigo

Presentación  


11:10 – 12:20 h 2nd SESSION: IMMUNOLOGY AND CANCER

11:25 – 11:40 h Immunotherapy resistance modes: primary, adaptative and acquired

Dr. Rafael Rosell, Hospital Universitari Germans Trias i Pujol-ICO, Badalona

Presentación  


11:40 – 11:55 h Microbiome and the modulation of the immune system

Dr. Andrés Moya, Universidad de Valencia

Presentación  


11:55 – 12:00 h Oral communication The zebrafish: a new model to understand the crosstalk between inflammation and cancer

Dr. Victoriano Mulero, Universidad de Murcia

Presentación  


12:00 – 12:05 h Oral communication Novel molecular mechanisms of immunoresistance and cancer stem cell activity

Dr. Ander Sáenz, Instituto de Investigación Sanitaria Biodonostia, Donostia

Presentación  


12:40 – 13:25 h RECENT ADVANCES IN BREAST CANCER

12:40 – 12:55 h Emerging therapeutic strategies

Dra. Eva Ciruelos, Hospital Universitario 12 de Octubre, Madrid

Presentación  


12:55 – 13:10 h Research advances towards disease eradication

Dr. Alberto Ocaña,Complejo Hospitalario Universitario de Albacete

Presentación  


14:25 – 15:10 h RECENT ADVANCES IN LUNG CANCER

14:25 – 14:40 h Emerging therapeutic strategies

Dra. Pilar Garrido,Hospital Universitario Ramón y Cajal, Madrid

Presentación  


14:40 – 14:55 h Research advances towards disease eradication

Dra. Montserrat Sánchez Céspedes,Institut d’Investigació Biòmedica
de Bellvitge-IDIBELL, Barcelona

Presentación  


15:10 – 15:55 h THE ASEICA FORUM. CURRENT STATUS OF RESEARCH IN SPAIN

15:10 – 15:25 h Speaker:

Dr. Joaquín Arribas, CIBERONC Director

Presentación  


15:55 – 17:20 h 3rd SESSION: ASEICA – SEOM NOVEL THERAPEUTIC TARGETS AND APPROACHES FOR THE TREATMENT OF CANCER

16:10 – 16:25 h Driver genes in hematological neoplasias: role of mutations in non-coding regions

Dr. Xosé Puente, Universidad de Oviedo

Presentación  


16:25 – 16:40 h Clinically relevant novel drivers in glioblastoma

Dr. Juan Manuel Sepúlveda, Hospital Universitario 12 de Octubre, Madrid

Presentación  


16:40 – 16:55 h Novel hallmarks of cancer

Dr. Alberto Ocaña, Complejo Hospitalario Universitario de Albacete

Presentación  


17:00 – 17:05 h Oral communication Novel therapeutic targets: aiming at VAV2 in Squamous Cell Carcinoma

Dr. Luis Francisco Lorenzo, Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC

Presentación  


Wednesday, November 15th 2017

09:00 – 10:00 h ASEICA & CIBER CAREER PROSPECTS FOR CANCER RESEARCHERS IN TRAINING

09:00 – 09:15 h The importance of mentorship

Dra. Ana Rio-Machin, CERU representative, London, UK

Presentación  


09:15 – 09:30 h Searching for a postdoctoral position

Dr. Amancio Carnero, Instituto de Biomedicina de Sevilla. Campus Hospital Universitario Virgen del Rocío

Presentación  


09:30 – 09:45 h Paving the way to a successful career in cancer research

Dra. Angélica Figueroa, Instituto de Investigación Biomédica de A Coruña-INIBIC

Presentación  


10:00 – 11:10 h 4th SESSION: LIQUID BIOPSY. CHASING CIRCULATING TRACES OF CANCER

10:15 – 10:30 h Use of circulating exosomes as surrogate markers of tumours, the future of the liquid biopsy?

Dr. Héctor Peinado, Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid

Presentación  


10:30 – 10:45 h Alternative forms of liquid biopsy

Dr. Miguel Abal, Instituto de Investigación Sanitaria de Santiago-IDIS/SERGAS, Santiago de Compostela

Presentación  


10:45 – 10:50 h Oral communication Identification of potentially druggable mutations using the liquid biopsy in familial PDAC

Dra. Julie Earl, Hospital Universitario Ramón y Cajal, Madrid

Presentación  


10:50 – 10:55 h Oral communication Clinical utility of plasma-based next-generation sequencing (NGS) for advanced NSCLC patients with insufficient or unavailable tumor tissue

Dra. Eloisa Jantus, Fundación Investigación Hospital General Universitario de Valencia

Presentación  


11:55 – 13:10 h ASEICA DEBATES WITH THE EXPERT: CANCER-SPECIFIC CHALLENGES

11:55 – 12:10 h Molecular classification in colon cancer

Dr. Héctor García Palmer, Hospital Universitari Vall d’Hebron, Barcelona

Presentación  


12:10 – 12:25 h Why is pancreatic cancer so difficult to treat?

Dr. Francisco X. Real, Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid

Presentación  


12:25 – 12:40 h Exploiting genomic instability in ovarian and prostate cancer: PARP inhibitors

Dr. Luis Manso, Hospital Universitario 12 de Octubre, Madrid

Presentación  


12:40 – 12:55 h Molecular classification in breast cancer

Dra. Laura García Estévez, Hospital Universitario HM Sanchinarro-CIOCC, Madrid

Presentación  


13:10 – 13:55 h RECENT ADVANCES IN PROSTATE CANCER

13:10 – 13:25 h Emerging therapeutic strategies

Dr. Daniel Castellano, Hospital Universitario 12 de Octubre, Madrid

Presentación  


13:25 – 13:40 h Research advances towards disease eradication

Dra. Rebeca Lozano, Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid

Presentación  


14:55 – 15:40 h RECENT ADVANCES IN COLON CANCER

15:10 – 15:25 h Research advances towards disease eradication

Dr. Gabriel Capellà, Institut d’Investigació Biòmedica de Bellvitge-IDIBELL, Barcelona

Presentación  


15:40 – 16:30 h THE NEW FRONTIER OF CANCER

15:45 – 16:25 h Speakers:

A clinical vision:

Dr. Luis Paz-Ares, Hospital Universitario 12 de Octubre, Madrid

Presentación  


A biological vision:

Dr. Ángel Carracedo, Universidad de Santiago de Compostela

Presentación  


16:30 – 17:45 h 5th SESSION: RESEARCH AND DIAGNOSTIC PLATFORMS

16:30 – 16:45 h Precision medicine and Big Data

Dr. Víctor Quesada, Universidad de Oviedo

Presentación  


16:45 – 17:00 h Delivering precision medicine in oncology today and in future

Dr. Joan Albanell, Hospital del Mar – Parc de Salut Mar, Barcelona

Presentación  


17:00 – 17:15 h Patient-derived xenograft applications

Dr. Alberto Villanueva, Hospital Duran i Reynals-ICO, Barcelona

Presentación  


17:15 – 17:20 h Oral communication New CRISPR/CAS9- based mouse model for the study of gliomas

Dr. Álvaro Curiel, Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid

Presentación  


17:20 – 17:25 h Oral communication Multifunctional theranostic nanoemulsions for targeted imaging and drug delivery in metastatic cancer

Dra. Sandra Díez, Fundación Ramón Domínguez, Santiago de Compostela

Presentación

 

Category: Sin categoría

Comments are closed.